Novel pharmaeutical interventions in experimental atherosclerosis and myocardial infarction Hoorn, Johanna Wijnanda Anthonia van der
9
0
0
Hele tekst
(2) .
(3)
(4)
(5) . . .
(6) !"# #$ %&&' #()*+ #"+"# "! #* , *(+ -.(/ *( 0 1 ." #" #!-/"! # *# +0(**"! ( 1 ,#0 # .1 1 0" $ 2(*-* *" #(# 2#(**" "#0(++(,*" -*# 3 45'64&64&%78'76&
(7)
(8) (*/9 *:)""
(9) #-99"#(; "9 $. ++"#! 0 . " #(*(),*(+*"+(+2 +9(!1+- #*"!.1< !("*+ ,(@"# +*# =""/ ,(6 "*(+ "#()"#)""(0 "# ("# #(+*1"#+>-(.. ("0"+ #!(+6 +? + A- (*1, (," "#/9 # !0" 9) # )" " !"##. . .
(10)
(11) ! !
(12) B
(13)
(14) !
(15)
(16) !
(17) "
(18) ! . # $% #% . *"# "#9#(;)() !")# ! /*# !"&( "#+(*"(* "(!"$ )"@ ) #"/*# )(,(/-+ #, 0# % !"#"(;!"$ )"+."+-(* "* ")" # #0*("+ *" "#!"!()" !!"#! )7&9*."#%&&' 999"CD CE--# !#. '( )
(19)
(20) )".#"*" -.#-))" (C4'C. . .
(21)
(22) ! .
(23)
(24) * +
(25)
(26) * "
(27) *
(28) , * . . #, # -9"0 #, # # "9"+ # F #(/". #, # $ ("++"G&( "#+(*"(* +*#(/*H #, # !"# #+" #, # F +*"#9 0 G&( "#+(*"(*&*#"/*H #, # A- - # #"+". "+*-!("+ #"+"*"!(*(+*"+(+2"#" "#,#0"! **"F -.(-+ .# *#1, A- (*1, (,"$(/("/"+$ "(!"$""*"# !+ "2#92 +( #*,( /( 1 +- #*"!.1+*# =""/ $ 916 ((/($ ,(6 "*(+ !"# ("# %( /( +- #*.1*""*"# !+" #*%-! *( !*" $ -##( +"*(/*() ,#*" -.(/ *(,*(+*"+(+(+)# *",-1 /92"!)"! . . .
(29) I
(30)
(31)
(32) J 0 !"##GC4C%6%&&8H. . .
(33) . . . . . . . . . . . . . . . . . . . . . F""# (*#!-/*( . . . 0!( (" ! *# +* *( ( *"#+/"#+(+< #" ("2 , *" *"*( , /0.( *(*"# 1
(34) KLMN . . . . . . . . . . . !. ( /((/#" +"+ .1#"!-/()" *(/" #"++( ! ! +0 !" "!+,/!"+*"#1! "+*"#*# +,"# #*"((""#O7 "(!" $#%"0(/"
(35) N . ! . . . . . . . . . . #. "2 /!"+*"#! .+# *( ((.(*# "&EE7& (+ 0#" ",,"/*( " ( #" "*() *"#+/!"#+(+* "@"*(0(."("O7 "(!"0(/" . . . . . . . . . . . !. !0"+ #* ! # +* *( !!(*( "!1 #"!-/" !" "! 0"* , *"#+/!"#+(+ ( "O7 "(!"*# +)"(/0(/" "#$%P& K'.()**+M . # . . . . . . . . . . !. - !",Q:R )(+**"+ )!(* @ #.!/9+ #)#"++(, #"6"-(+*() *"#+/!"#+(+( "O7 "(!" .%*# +)"(/0(/" . . . . . . . . . . ///. * , ))#"++( " /!"+*"#! !2"#() *" *#0.- "6 #+* (! #"/" *# * )(+* 'C'''D G*"#-*#. H .!/9+ *" #)#"++( , *"#+/!"#+(+ ( "O7 "(!"*# +)"(/0(/" . . .
(36) . $ . . . . . . . . . /0. . ") *( "",,"/*+, #,"/-(. *#" *0"*/ #!( /,-/*( ,*"#(+/"0( 6#" "#,-+( (;-#1("O7 "(!"0(/" #" #" "*"!.1/0.("!*#" *0"*2(**#0.- "6 #+* (!#"/" *# * )(+*'C'''DG*"#-*#. H %%1 N K(M'L()PM+N . ! . . . . . . . . . /!2. F""# !!(+/-++( !,-*-#" "#+ "/*( "+ .
(37)
(38) . . . . . . . . . . /2. . . . . . . . . /!. . . . . . . . /#. . . . . . . . /#!. .
(39) 3 . 3 .
(40) . . . .
(41) . . .
(42)
GERELATEERDE DOCUMENTEN
Vaccination against CD99 induces T cell-mediated lysis of cells expressing CD99 We developed a vaccination strategy based on the induction of CD99 specific cytotoxic T cells
In addition to the effect of IL-16 vaccination on initial lesion formation after 8 weeks of Western type diet, we assessed the result of IL-16 vaccination on advanced
IFN-, IL-5 and IL-4 production by spleen and peritoneal cells Spleen and peritoneal cells isolated from mice that received two weeks of western type diet feeding and treatment
Single cell suspensions of spleens of control and CD127 vaccinated mice were prepared and FACS was used to determine the percentage of CD4 and CD8 positive T cells,
Not only minimizing migration of pro-atherogenic cells can provide protection against atherogenesis, inhibition of activated T cell signaling and co-stimulation can lead to
Niet alleen de vaatwand speelt een rol bij het ontstaan van atherosclerose maar ook de activatie en migratie van immuuncellen is hierbij betrokken.. Naast de regulatie van
Van Es T, Hauer AD, van Puijvelde GHM, v van Wanrooij EJA, de Vos P, Peterse N, van Berkel TJC, Kuiper J: DNA vaccination against IL-17 attenuates atherosclerosis in LDL
Het aantal additionele proeven dat bij de revisie van een artikel mag worden gevraagd, moet begrensd zijn door de bereidheid van het tijdschrift om de verkregen data naar behoren
